Helse ·
Hepatitis B, Measles, and Rare Therapies
Kilder
- STAT: STAT+: GSK picks up hep B drug approval
- Fierce Biotech: Amid bepirovirsen triumph, GSK quietly scraps trial of next-gen hep B therapy - Fierce Biotech
- BioPharma Dive: GSK, Ionis win US approval for first-of-its-kind hepatitis B drug - BioPharma Dive
- STAT: A counterintuitive way to build trust in measles vaccines and public health
- Thehill: Pennsylvania warns of congenital measles risk as cases rise - The Hill
- STAT: STAT+: Mark Cuban wants to crack open the market for rare disease treatments
- STAT: GSK picks up hep B drug approval - STAT
- Beckershospitalreview: FDA approves 1st generic weekly hormone patch
- MedPage Today: Generic of Combination Hormone Therapy Patch Approved for Women - MedPage Today
- Drugtopics: FDA Approves First Generic for Climara Pro Hormone Therapy Patch - Drug Topics
- Medicalxpress: First generic combo hormone patch could make menopause relief more affordable - Medical Xpress
- STAT: STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved
- STAT: GSK picks up hep B drug approval - STAT
- STAT: Nigeria identifies travel-related Ebola case
- BBC: Nigeria confirms Ebola case linked to East Africa - BBC
- Newscord: Nigeria Confirms First Ebola Case In Abuja, Traces 44 Contacts After Uganda Travel: 18 outlets compared - NewsCord
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.